Lymp-rich Hodgkin lymphoma, intrathorac nodes is a subtype of Hodgkin lymphoma characterized by the presence of lymphocytes in the intrathoracic lymph nodes. This condition is clinically significant as it can lead to respiratory complications and requires accurate diagnosis for effective treatment. The ICD-10 Code C81.42 facilitates precise documentation, billing, and public health reporting, ensuring that healthcare providers can track and manage this specific lymphoma subtype effectively.
ICD-10 Code C81.42 represents Lymp-rich Hodgkin lymphoma localized in the intrathoracic lymph nodes. This code is used when documenting cases of Hodgkin lymphoma that specifically affect the lymph nodes within the thoracic cavity. It is essential for accurate clinical documentation and billing, particularly when distinguishing this subtype from other forms of lymphoma.
Lymp-rich Hodgkin lymphoma, intrathorac nodes is a rare form of Hodgkin lymphoma that primarily affects the lymphatic system within the thoracic region. The etiology is not fully understood, but it is believed to involve genetic and environmental factors. This condition can progress rapidly, necessitating prompt medical intervention to prevent complications such as respiratory distress.
ICD-10 Code C81.42 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of patients with Lymp-rich Hodgkin lymphoma affecting the intrathoracic nodes. This code aids in capturing the severity and specifics of the condition, ensuring comprehensive patient care in both acute and chronic settings.
In SOAP notes, ICD-10 Code C81.42 connects subjective patient reports and objective clinical findings to a formal diagnosis of Lymp-rich Hodgkin lymphoma. This linkage is crucial for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
The management of Lymp-rich Hodgkin lymphoma, intrathorac nodes often requires hospitalization due to the potential for respiratory complications. Treatment typically involves chemotherapy and may include radiation therapy.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C81.42 is critical in medical billing, particularly in hospital and oncology settings, to ensure accurate reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 99214 | Established patient office visit, moderate complexity. |
| 77014 | Radiologic guidance for needle placement. |
Common Questions About Using ICD-10 Code C81.42 for Lymp-rich Hodgkin lymphoma, intrathorac nodes
What are the common symptoms of Lymp-rich Hodgkin lymphoma?
Common symptoms include swollen lymph nodes, persistent cough, chest pain, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and itching.
How is Lymp-rich Hodgkin lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies such as CT scans, and biopsy of affected lymph nodes to confirm the presence of Reed-Sternberg cells.
What treatment options are available for Lymp-rich Hodgkin lymphoma?
Treatment usually includes chemotherapy, often with the ABVD regimen, and may involve radiation therapy for localized disease. Supportive care is also important to manage symptoms.
Is Lymp-rich Hodgkin lymphoma curable?
Yes, Lymp-rich Hodgkin lymphoma is considered highly treatable, with many patients achieving remission through appropriate chemotherapy and radiation therapy.
Clinical Notes
SOAP notes
DAP notes
AI medical notes